114 related articles for article (PubMed ID: 3298085)
1. In vitro activity of aztreonam, cefuroxime and ceftazidime against gram-negative rods isolated from hospital patients with urinary tract infection.
Webb G; Robbins MJ; O'Hare MD; Felmingham D; Ridgway GL; Grüneberg RN
Int J Clin Pharmacol Res; 1987; 7(3):203-5. PubMed ID: 3298085
[TBL] [Abstract][Full Text] [Related]
2. The comparative activity of twelve 4-quinolone antimicrobials against gram-positive and gram-negative anaerobes.
Robbins MJ; O'Hare MD; Felmingham D; Ridgway GL; Grüneberg RN
Drugs Exp Clin Res; 1985; 11(7):431-4. PubMed ID: 3836865
[TBL] [Abstract][Full Text] [Related]
3. The comparative activity of twelve 4-quinolone antimicrobials and sulphadiazine against Neisseria meningitidis.
Felmingham D; Wall RA
Drugs Exp Clin Res; 1985; 11(7):427-9. PubMed ID: 3939218
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of vancomycin and teicoplanin against anaerobic bacteria.
Robbins MJ; Marais R; Felmingham D; Ridgway GL; Grüneberg RN
Drugs Exp Clin Res; 1987; 13(9):551-4. PubMed ID: 2962846
[TBL] [Abstract][Full Text] [Related]
5. The effect of carbon dioxide on the in vitro activity of erythromycin and RU-28965 against anaerobic bacteria.
Felmingham D; Robbins MJ; Marais R; Ridgway GL; Gruneberg RN
Drugs Exp Clin Res; 1987; 13(4):195-9. PubMed ID: 3113907
[TBL] [Abstract][Full Text] [Related]
6. [Comparative in vitro activity of 2 monobactams (RO 172301 (AMA 1080)and aztreonam), ceftazidime and cefotaxime on Gram-negative bacilli].
Thabaut A; Meyran M; Huerre M
Pathol Biol (Paris); 1985 May; 33(5):404-7. PubMed ID: 3929217
[TBL] [Abstract][Full Text] [Related]
7. ['In vitro' activity of different antimicrobial agents on Gram-negative nonfermentative bacilli, excluding Pseudomonas aeruginosa and Acinetobacter spp].
Vay CA; Almuzara MN; Rodríguez CH; Pugliese ML; Lorenzo Barba F; Mattera JC; Famiglietti AM
Rev Argent Microbiol; 2005; 37(1):34-45. PubMed ID: 15991478
[TBL] [Abstract][Full Text] [Related]
8. Potency and spectrum trends for cefepime tested against 65746 clinical bacterial isolates collected in North American medical centers: results from the SENTRY Antimicrobial Surveillance Program (1998-2003).
Sader HS; Fritsche TR; Jones RN
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):265-73. PubMed ID: 16105569
[TBL] [Abstract][Full Text] [Related]
9. [Aztreonam: monocenter microbiological study with prevention experience in surgery].
Malcangi A; Pesce S; Vitale M; Martinetto P
G Batteriol Virol Immunol; 1987; 80(1-12):237-51. PubMed ID: 3509031
[TBL] [Abstract][Full Text] [Related]
10. [Urinary infection. I. Comparative in vitro activities of several antibiotic drugs against Gram-negative bacteria].
Giachino F; Allocco A; Tuninetti L; Tullio V; Cuffini AM; Carlone NA
G Batteriol Virol Immunol; 1992 Jan-1993 Dec; 85(1-12):55-67. PubMed ID: 7498617
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
Sader HS; Jones RN; Dowzicky MJ; Fritsche TR
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):203-8. PubMed ID: 16105565
[TBL] [Abstract][Full Text] [Related]
12. Carumonam's in-vitro activity against gram-negative bacteria and its stability to their beta-lactamases.
Raimondi A; Mattina R; Cocuzza CE
Chemioterapia; 1988 Feb; 7(1):3-9. PubMed ID: 3288365
[TBL] [Abstract][Full Text] [Related]
13. Comparative activity of ceftazidime and four other cephalosporins against gram-negative bacteria and their sensitivity to beta-lactamases.
Galante D; Esposito S; Barba D; Pennucci C; Limauro D; Scioli C
Chemioterapia; 1984 Aug; 3(4):250-4. PubMed ID: 6398123
[TBL] [Abstract][Full Text] [Related]
14. How and why aztreonam works.
Rittenbury MS
Surg Gynecol Obstet; 1990; 171 Suppl():19-23. PubMed ID: 2244291
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial activity of aztreonam: a synthetic monobactam. A comparative study with thirteen other antibiotics.
Paradelis AG; Stathopoulos GA; Salpigides GN; Crassaris LG
Methods Find Exp Clin Pharmacol; 1983; 5(6):375-83. PubMed ID: 6684718
[TBL] [Abstract][Full Text] [Related]
16. Comparative in vitro activity of aztreonam and other antimicrobial agents against Salmonella species.
Paradelis AG; Delidou K; Stavrakis AO; Crassaris LG
Drugs Exp Clin Res; 1985; 11(3):163-7. PubMed ID: 3836124
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of the in vitro activity of aztreonam on 1990 gram-negative bacterial strains recently isolated in Campania hospitals].
Covelli I; Bolletti-Censi M; Fortunato A; Guarino A; Spagnoletti G; Amato G; Nani E; Anzivino D; Lavitola A; Gulletta E
Boll Ist Sieroter Milan; 1986; 65(1):22-31. PubMed ID: 3521671
[TBL] [Abstract][Full Text] [Related]
18. The activity of ceftazidime compared with those of aztreonam, newer cephalosporins and Sch 29482 against nonfermentative gram-negative bacilli.
Schell RF; Francisco M; Bihl JA; LeFrock JL
Chemotherapy; 1985; 31(3):181-90. PubMed ID: 3888543
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of tigecycline against 3989 Gram-negative and Gram-positive clinical isolates from the United States Tigecycline Evaluation and Surveillance Trial (TEST Program; 2004).
Bouchillon SK; Hoban DJ; Johnson BM; Johnson JL; Hsiung A; Dowzicky MJ;
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):173-9. PubMed ID: 16105561
[TBL] [Abstract][Full Text] [Related]
20. [Chemobiotic sensitivity of common Gram-negative bacteria in urinary tract infections, 1981-1982].
Mastandrea P; Delli Carri P
Quad Sclavo Diagn; 1983 Dec; 19(4):455-62. PubMed ID: 6377362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
